Literature DB >> 24769273

Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects.

Robin P F Dullaart1, James D Otvos2, Richard W James3.   

Abstract

OBJECTIVES: We determined relationships of the anti-oxidative enzyme, paraoxonase-1 (PON-1), with high density lipoprotein (HDL) subfractions, and tested whether these relationships are stronger than those with HDL cholesterol and apolipoprotein A-I (apoA-I) in subjects with and without type 2 diabetes mellitus (T2DM). DESIGN AND METHODS: Serum PON-1 (arylesterase activity) and HDL subfractions (nuclear magnetic resonance spectroscopy) were determined in 67 T2DM patients and in 56 non-diabetic subjects.
RESULTS: PON-1 activity, HDL cholesterol and apoA-I were decreased in T2DM (all p<0.05). The HDL particle concentration was unaltered, but large HDL particles, medium HDL particles and HDL particle size were decreased, whereas small HDL particles were increased in T2DM (all p<0.05). PON-1 was more closely related to HDL cholesterol than to apoA-I (p=0.001). In turn, the positive relationship of PON-1 with the HDL particle concentration and with large HDL particles was stronger than that with HDL cholesterol (both p<0.01). The inverse relationship of PON-1 with T2DM was only modestly attenuated by HDL cholesterol or HDL particle characteristics.
CONCLUSIONS: PON-1 activity is more closely related to the HDL particle concentration or large HDL particles than to HDL cholesterol. Impaired PON-1 activity in T2DM is not to a considerable extent explained by altered HDL subfraction levels.
Copyright © 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  High density lipoprotein subfractions; High density lipoproteins; Paraoxonase-1 activity; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2014        PMID: 24769273     DOI: 10.1016/j.clinbiochem.2014.04.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  15 in total

1.  Relation of Paraoxonase 1 Activity with Biochemical Variables, Brachial Artery Intima-Media Thickness in Patients with Diabetes with or without Obesity.

Authors:  Pinar Karakaya; Bahar Ozdemir; Meral Mert; Yildiz Okuturlar
Journal:  Obes Facts       Date:  2018-02-14       Impact factor: 3.942

2.  Paraoxonase 1 Activity, Lipid Profile, and Atherogenic Indexes Status in Coronary Heart Disease.

Authors:  Mostafa Cheraghi; Gholamreza Shahsavari; Ali Maleki; Hassan Ahmadvand
Journal:  Rep Biochem Mol Biol       Date:  2017-10

3.  Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.

Authors:  Htet W Khine; John F Teiber; Robert W Haley; Amit Khera; Colby R Ayers; Anand Rohatgi
Journal:  Atherosclerosis       Date:  2017-06-03       Impact factor: 5.162

4.  Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol.

Authors:  Eline H van den Berg; Eke G Gruppen; Richard W James; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Lipid Res       Date:  2018-11-19       Impact factor: 5.922

Review 5.  Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

Authors:  Carlo Cervellati; Giuseppe Valacchi; Veronica Tisato; Giovanni Zuliani; Judit Marsillach
Journal:  Minerva Med       Date:  2018-10-11       Impact factor: 4.806

6.  HIV infection induces structural and functional changes in high density lipoproteins.

Authors:  Marc O Siegel; Alison G Borkowska; Larisa Dubrovsky; Mary Roth; Ruth Welti; Afsoon D Roberts; David M Parenti; Gary L Simon; Dmitri Sviridov; Samuel Simmens; Michael Bukrinsky; Michael L Fitzgerald
Journal:  Atherosclerosis       Date:  2015-08-29       Impact factor: 5.162

7.  Aerobic training modulates the effects of exercise-induced oxidative stress on PON1 activity: a preliminary study.

Authors:  Aneta Otocka-Kmiecik; Marek Lewandowski; Urszula Szkudlarek; Dariusz Nowak; Monika Orlowska-Majdak
Journal:  ScientificWorldJournal       Date:  2014-10-14

Review 8.  The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.

Authors:  Marek Femlak; Anna Gluba-Brzózka; Aleksandra Ciałkowska-Rysz; Jacek Rysz
Journal:  Lipids Health Dis       Date:  2017-10-30       Impact factor: 3.876

9.  HDL Cholesterol Efflux Capacity is Impaired in Severe Short-Term Hypothyroidism Despite Increased HDL Cholesterol.

Authors:  Trynke van der Boom; Congzhuo Jia; Joop D Lefrandt; Margery A Connelly; Thera P Links; Uwe J F Tietge; Robin P F Dullaart
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

10.  HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study.

Authors:  Sara Sokooti; Jose L Flores-Guerrero; Lyanne M Kieneker; Hiddo J L Heerspink; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.